Jiujiang Defu Technology Co., Limited (SHE:301511)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,499	7,917	10,441	-	-	-
Market Cap Growth	-24.17%	-24.17%	-	-	-	-
Enterprise Value	31,109	12,540	13,515	-	-	-
Last Close Price	42.04	12.56	16.52	-	-	-
PE Ratio	-	-	78.72	-	-	-
PS Ratio	3.39	1.01	1.60	-	-	-
PB Ratio	5.79	1.73	2.11	-	-	-
P/TBV Ratio	7.30	2.18	2.65	-	-	-
EV/Sales Ratio	3.99	1.61	2.07	-	-	-
EV/EBITDA Ratio	131.91	53.17	32.02	-	-	-
EV/EBIT Ratio	-	-	80.26	-	-	-
Debt / Equity Ratio	1.31	1.31	1.31	1.23	0.78	0.77
Debt / EBITDA Ratio	25.38	25.38	15.31	3.85	2.01	5.46
Asset Turnover	0.54	0.54	0.55	0.81	0.91	0.55
Inventory Turnover	4.66	4.66	4.18	5.95	6.34	4.70
Quick Ratio	0.75	0.75	0.81	0.66	0.97	0.61
Current Ratio	0.96	0.96	1.07	0.90	1.27	0.84
Return on Equity (ROE)	-7.08%	-7.08%	2.82%	24.09%	37.03%	0.85%
Return on Assets (ROA)	-0.44%	-0.44%	0.88%	6.57%	10.74%	1.07%
Return on Capital (ROIC)	-0.58%	-0.58%	1.15%	9.52%	17.63%	2.11%
Return on Capital Employed (ROCE)	-	-	2.60%	18.40%	22.70%	3.40%
Earnings Yield	-0.92%	-3.10%	1.27%	-	-	-
FCF Yield	-4.90%	-16.42%	-18.52%	-	-	-
Dividend Yield	0.11%	-	0.24%	-	-	-
Payout Ratio	-	-	108.31%	19.85%	11.43%	191.68%
Buyback Yield / Dilution	-56.37%	-11.69%	-5.40%	-3.91%	-60.40%	-6.42%
Total Shareholder Return	-56.26%	-11.69%	-5.16%	-3.91%	-60.40%	-6.42%

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.